- Open Access
Human 14-3-3 gamma protein results in abnormal cell proliferation in the developing eye of Drosophila melanogaster
© Hong et al; licensee BioMed Central Ltd. 2008
Received: 31 July 2007
Accepted: 14 January 2008
Published: 14 January 2008
14-3-3 proteins are a family of adaptor proteins that participate in a wide variety of cellular processes. Recent evidence indicates that the expression levels of these proteins are elevated in some human tumors providing circumstantial evidence for their involvement in human cancers. However, the mechanism through which these proteins act in tumorigenesis is uncertain.
To determine whether elevated levels of 14-3-3 proteins may perturb cell growth we overexpressed human 14-3-3 gamma (h14-3-3 gamma) in Drosophila larvae using the heat shock promoter or the GMR-Gal4 driver and then examined the effect that this had on cell proliferation in the eye imaginal discs of third instar larvae. We found that induction of h14-3-3 gamma resulted in the abnormal appearance of replicating cells in the differentiating proneural photoreceptor cells of eye imaginal discs where h14-3-3 gamma was driven by the heat shock promoter. Similarly, we found that driving h14-3-3 gamma expression specifically in developing eye discs with the GMR-Gal4 driver resulted in increased numbers of replicative cells following the morphogenetic furrow. Interestingly, we found that the effects of overexpressing h1433 gamma on eye development were increased in a genetic background where String (cdc25) function was compromised.
Taken together our results indicate that h14-3-3 gamma can promote abnormal cell proliferation and may act through Cdc25. This has important implications for 14-3-3 gamma as an oncogene as it suggests that elevated levels of 14-3-3 may confer a growth advantage to cells that overexpress it.
The 14-3-3 proteins are found abundantly in cytoplasm of brain neuronal cells [1, 2] and are highly conserved in organisms as diverse as yeast, Drosophila, and humans [3, 4]. Only two isoforms, ε and ζ are expressed in Drosophila  and yeast [5, 6]. However, in mammals, there are seven family members and each is designated with a Greek letter (ε, γ, η, σ, θ/τ). Phosphorylated isoforms of β and ζ, respectively, are known as ΰ and δ . All 14-3-3 family members have been shown to function in various aspects of crucial cellular processes including cell cycling regulation [8, 9], apoptosis [10, 11], transcriptional regulation [12, 13] and Ras/Raf signaling .
The diversity of activities in which 14-3-3 proteins act is due to their ability to interact with a wide variety of signaling molecules through a variety of consensus motifs that typically consist of a phosphoserine residue flanked by an arginine and proline such as RXY(F)XpS(pT)XP and RSxpS(pT)xP (x stands for any amino acid, and pS refers to phosphorylated Serine), but may also bind to motifs that are serine-rich or to apparently unrelated motifs such as GHSL and WLDLE [3, 15]. An added complexity is that 14-3-3s form thermodynamically stable dimers and each family member has a distinct preference for formation of either homo- or hetero-dimers providing a diversity of architectures for protein interactions . For instance the γ protein forms homodimers as well as having a heterodimeric formation with the ε protein . Conversely, the ε protein does not homodimerize, and instead prefers to heterodimerizes with other family members (η, β, γ, ζ) . As a consequence, 14-3-3 proteins can regulate and/or influence the activity of a wide variety of proteins which accounts for their involvement in such a wide range of normal cellular processes.
Perhaps the best characterized cellular process that 14-3-3 is involved in is the ability to regulate cell cycle progression . Detailed studies in yeast show that 14-3-3 binds to the key cell cycle regulator, Cdc25, in response to DNA damage which leads to Cdc25 being exported from the nucleus . This checkpoint activation results in cells halting their entry into mitosis which facilitates the repair of DNA damage . 14-3-3 proteins ε and γ play a similar role in regulating G2/M progression in humans [9, 16, 18]. Moreover, 14-3-3ζ was also shown to bind with Cdc25C in A549 lung cancer cells after irradiation . Collectively, these studies show that 14-3-3 proteins play a role in maintaining genomic integrity.
The involvement of 14-3-3 proteins in cellular process that may be relevant to their role in human cancer is not limited to regulation of cell cycle checkpoints nor are ε and ζ the only family members that could have a role in tumorigeneis. For instance, exogenous expression of 14-3-3β increases proliferation of NIH3T3 cells and confers the ability to grow in soft agar . 14-3-3θ was shown to induce the expression of tenascin-C (overexpressed in most solid tumors) which increase cell adhesion of mammalian MCF-7 carcinoma cells on a substratum . Moreover, the expression levels of most 14-3-3s are elevated in lung and other cancers suggesting that they confer a growth advantage to neoplastic cells .
In these studies we chose to focus on the 14-3-3γ protein because we found that this family member was consistently upregulated in human lung cancers and when introduced into H322 lung cancer cells caused polyploidization suggesting that it might have potential oncogenicity [22, 23]. Because flies have two 14-3-3 proteins that act on the same signaling pathways and cellular processes in human cells that are involved in carcinogenesis we chose Drosophila for our model system [4, 24–27]. Consequently we utilized this genetically tractable model organism to examine the effect that targeted overexpression of h14-3-3γ had on cell cycling in the developing eye and found that 14-3-3γ stimulated abnormal cell proliferation in neuronal cells of the differentiating eye imaginal discs. We also examined genetic interactions between String (Drosophila Cdc25C homolog) and h14-3-3γ in terms of cell cycling regulation in fly eyes.
Overexpression of human 14-3-3γ leads to abnormal cell proliferation in differentiating eye imaginal discs
We next optimized the conditions used for induction of h14-3-3γ protein. We found that a one hour heat shock treatment consistently resulted in robust induction of h14-3-3γ protein, whereas with a 30 minute heat-shock the amount of protein expressed was weak (Figures 1B &1C). Importantly, heat shock had no effect on expression of the endogenous Drosophila ε and ζ 14-3-3 genes (data not shown). Recovery time was also an important determinant for maximizing the h14-3-3γ protein expression. We found that h14-3-3γ protein expression was most highly elevated 1–3 hours after a one hour heat shock treatment (Figures 1B; Lane 6 &1C; Lanes 4–5). Neither the exogenous h14-3-3γ protein nor endogenous 14-3-3 protein could be detected in the control flies. This may be caused by the fact that only human 14-3-3γ protein could be detected in the transgenic line by using a pan-specific 14-3-3 antibody, which was raised against human 14-3-3β protein (Figure 1). Since the levels of h14-3-3γ protein declined to near background 4.5 hours after treatment (Figure 1C; Lane 5) all animals exposed to heat shock were examined within 1–3 hours after treatment.
H14-3-3γ stimulates abnormal cell proliferation in eye imaginal discs
Frequency of BrdU incorporation in the posterior region of morphogenetic furrow in h14-3-3γ transgenic lines
Flies bearing transgene h14-3-3γ *
Heat-shock induction of transgene
Numbers of cells in "S" phase
Numbers of eye imaginal discs observed
4.14 (± 1.03)
8.29 (± 3.11)
9.90 (± 1.92)
11.0 (± 5.69)
Both HS1433GA & HS1433GC
8.0 (± 1.91)
20.5 (± 2.32)a
H14-3-3γ protein controls S phase cell prolongation
Our experiments with the Hsp70 promoter-driven h14-3-3γ gene suggested that the overexpression of the 14-3-3γ resulted in aberrant cellular proliferation. To confirm our results we made additional flies in which h14-3-3γ expression was specifically targeted to behind of the morphogenetic furrow of posterior compartment of 3rd-instar eye imaginal discs using a GMR (Glass Multiple Reporter)-Gal4  driver. Transgenic UAS-h1433 γ (on 2nd chromosome, #15D) flies were created as described in the Methods section. Crossing Gal4 flies with UAS-h1433 γ flies induced expression of h1433γ in eye imaginal discs.
Induction of the rough eye phenotype by h14-3-3γ in a heterozygous String genetic background
Flies bearing transgene h14-3-3γ
Stg9A genetic background
Rough eye phenotype (%)
Numbers of flies observed
Collectively our results suggest that overexpression of human 14-3-3γ leads to the abnormal appearance of replicating cells in eye imaginal discs where such cells would normally not appear. Although the effect was modest, the appearance of abnormally proliferative cells was reproducible when h14-3-3γ gene copy number was increased. It is unclear why the effect of h14-3-3γ overexpression was slight. One possibility is that h14-3-3γ, which likely evolved from the other isoforms, has only partially overlapping functions with the endogenous 14-3-3γ. In any case, overexpression of h14-3-3γ resulted in replicating cells appearing amongst differentiated neuronal cells posterior to the morphogenetic furrow in eye imaginal discs. These BrdU-incorporating cells could result from h14-3-3γ causing differentiated cells to become abnormally replicative or because h14-3-3γ causes replicative cells to remain in the replicative phase for a prolonged period. We favor the latter hypothesis. Progression of the morphogenetic furrow through the undifferentiated eye disc is precisely regulated. The number of replicating cells that arise in the wake of the morphogenetic furrow is tightly controlled and is typically about two cells deep. However, in the eye imaginal discs of flies where h14-3-3γ is driven by GMR-Gal4 the width of the band of proliferative cells is increased to between 3–4 cells. Concomitantly, we showed that h14-3-3γ suppressed the appearance of mitotic cells in the eye discs of these same flies. This is consistent with data from our lab and with what has been shown for another 14-3-3 family member 14-3-3σ  and could indicate that 14-3-3γ is involved in the process that prolonging replicative phase of cells delay entry into mitosis. Indeed, in previous studies we showed that 14-3-3γ caused cells to reenter S phase when overexpressed in a lung cancer cell line .
The primary conclusion from these studies is that h14-3-3γ leads to abnormal cell proliferation when overexpressed and that proliferation is evident even after the tissue has become differentiated. This has important implications for h14-3-3γ as an oncogene as it suggests that elevated levels of the protein can interfere with normal cell cycle progression.
Generation of transgenic fly stocks and genetic crosses
For ubiquitous h14-3-3γ protein expression, we generated two transgenic lines that express gamma using a P-element vector in which the h14-3-3γ gene was driven by the Hsp70 heat shock promoter and could be activated by heat shock. Two independent lines were generated, HS1433GA (on X chromosome) and HS1433GC (on 3rd chromosome). To increase gene copies (more than 2) of h14-3-3γ progeny, these flies were crossed with each other and selected using eye color as a marker for gene dosage. A stock homozygous for 14-3-3γ on the X and 3rd chromosome was established from this cross and has remained stable for an extended period of time.
Stock flies with GMR-Gal4 driver were crossed with 8 UAS-h14-3-3γ transgenic lines for initial screening, and we found all lines to be similar. For the experiments in this study, male flies of h14-3-3γ on the 2nd chromosome (P33#15D) were crossed with GMR-Gal4 (on 2nd chromosome) female flies to generate recombinant flies for the experiments and scored for eye phenotype. Recombinant flies bearing both UAS-h14-3-3γ and GMR-Gal4 on the second chromosome were balanced with CyO balancer chromosome. Virgin female homozygous GMR-Gal4, UAS-h14-3-3γ flies were selected to cross with homozygous male UAS-GFP (2nd chromosome) flies (Figures 4 and 5).
Using those increased dosage of hs-1433γ flies,. we crossed on h14-3-3γ transgenes into a String mutant genetic background. String is a homologue of Cdc25, and the allele of Stg9A (a kind gift from Dr. Patrick O'Farrell) is known to be temperature-sensitive. On the 3rd chromosome, Stg9A is balanced with TM3 (third multiple 3) having Sb' (Stubble) as a dominant marker . To examine eye phenotypes in adults expressing h14-3-3γ in Stg9A heterozygotes, we treated the flies with multiple heat-shocks (a 30 min heat pulse at 37°C every 7 and a half hours) starting from 3rd-instar larval stage.
RT-PCR was performed using total RNA extracted from adult flies or 3rd-instar larvae. For the total RNA extraction, a FastRNA Pro Green kit (Qbiogene) was used and followed the manufacturer's instructions. For Reverse Transcription (RT), a mixture of Oligo-dT, dNTPs (10 mM), RNA (5 μg), and DEPC- ddH2O was incubated for 5 min at 6°C. The RT contents were collected at the bottom by centrifuging, and 5 × buffer, 0.1 M DTT and RNAse inhibitor were added. After they were incubated for 2 minutes at 42°C, 1 μl Superscript II RT was added. For PCR reactions, a mixture of 41 μl Platinum Supermix (Invitrogen), 3 μl DMSO, 10 mM dNTP, DNA Digest 1 (1 μg of Total RNA, 10× DNAase free buffer, DNAase, ddH2O up to 10 μl) and 10 μM each forward and reverse primer for 1433γ cDNA were added (Forward, CTGAATGAGCCACTGTCGAA; Reverse, CACACAGCCTCCAACTCCTT). Drosophila ribosomal protein 49 encoding gene (dRP49) was used as a loading control for the PCR reactions. The primer sequences to flank dRP49 were 5'-GTGTATTCCGACCACGTTACA (RP49-antisense) and 5'-TCCTACCAGCTTCAAGATGAC (RP49-sense).
Cell lyses were performed on ice by using 3rd-instar larval imaginal discs in RIPA buffer. Total protein 50 μg per lane was loaded on a SDS/PAGE gel. The protein bands were transferred onto Nitrocellulous membranes (BioTrace NT, Pall Corporation) in transfer buffer (89.3 g glycine, 19.3 g Tris, 1.6 L Methanol, ddH2O up to 8 L) for overnight on a Transphor Unit (Amersham Biosciences, Cat # 80-6205-97). Then, a primary antibody, mouse anti-14-3-3β antibody (pan-specific antibody detecting all human 14-3-3 isoforms, Santa Cruz, Cat # SC1657), was used at a 1:100 dilution at 4°C for overnight. A goat anti-mouse secondary antibody was diluted 1:5000 in PBST (1 × PBS + 0.1% Tween 20) buffer with 5% Non-Fat Dry Milk, and the membrane was incubated in the secondary antibody for 2 hrs at room temperature. Using an ECL detection kit (Pierce), specific protein bands were detected onto X-ray films (Kodak) using an autoradiographic machine (Konica SRX-101A). The membranes were stripped in 0.1 M NaOH for 5 min at room temperature and treated with a loading control anti-beta-actin antibody(AbCam).
Mature 3rd-instar larvae were collected from controls (Wild Types) and 1433γ overexpressing animals. Heat-shock treatment was performed for 1 hr at 37°C in a water bath. After the heat-shock treatment, 1 hr of recovery time was given. For fixation, imaginal discs were dissected and immediately treated with 5% paraformaldehyde for 30 min. Tissues were washed twice for 10 min. in PBST (1 × PBS, 0.1% Triton ×-100). For a blocking step, 1% Normal Goat Serum (NGS) was added to PBST and treated for 30 min. A neuronal cell marker, rat anti-elav antibody was diluted 1:200. An anti-pH3 (phosphorylated Histone H3 at Serine 10, Upstate Biotechnology) antibody was used at 1:250 dilution.
The primary antibodies were added and incubated for overnight at 4°C. The antibody rat anti-elav was obtained from the Developmental Studies Hybridoma Bank at the University of Iowa. FITC- or TRITC-labeled secondary antibodies (KPL) were treated for 2 hr at room temperature. After washing in PBS-T and PBS-BT (PBST + 0.5% BSA), the tissues were mounted in Mowiol mounting medium (Calbiochem, Cat # 475904).
The BrdU (Bromodeoxyuridine) incorporation was performed in 1 × PBS with 5 μg/ml BrdU for 1 hr at room temperature with gentle shaking on Nutator. Imaginal discs were fixed in 5% paraformaldehyde for 30 min, and washed for 5 min 3× in PBST (1 × PBS, 0.3% Triton ×-100). Then, the tissues were treated with 2 N HCl for 30 min and neutralized for 2 min in 100 mM Borax (Sigma). A primary antibody, mouse anti-BrdU (Becton Dickinson) was used at a 1:20 dilution in a mixture of PBST and 5% NGS (Vector Labs). The primary antibody incubation was done at 4°C overnight. A goat-anti mouse TRITC-labeled secondary antibody (Jackson ImmunoResearch) was used at a 1:200 dilution and the imaginal discs were treated for 2 hrs at room temperature. The discs were mounted using Vectashield mounting medium (Vector Labs).
Confocal laser scanning and fluorescence microscopic studies
Confocal images were collected by using a Confocal Microscope (Nikon Eclipse E800). For screening of the immunostaining, a fluorescence microscope (Nikon Eclipse E800) with X-cite 120 (Fluorescence Illumination Systems) was also utilized. The microscopic images were analyzed by using an Adobe Photoshop 7 software.
We would like to thank to Dr. Danny Brower and Dr. William Staaz for their helpful comments on this manuscript. We appreciate for Dr. Carl Boswell's expertise in Confocal Microscopy. We also thank to Zuohe Song for helping us with the generation of transgenic flies, and Daniel Hernandez for his help with maintaining our stock flies. The monoclonal antibody anti-rat-elav (7E8A10) developed by Dr. Gerald Rubin was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242. This work was supported by NIH grant number CA107510.
- Ichimura T, Isobe T, Okuyama T, Takahashi N, Araki K, Kuwano R, Takahashi Y: Molecular cloning of cDNA coding for brain-specific 14–3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc Natl Acad Sci U S A 1988, 85: 7084–7088. 10.1073/pnas.85.19.7084View ArticlePubMed CentralPubMedGoogle Scholar
- Komori T, Ishizawa K, Arai N, Hirose T, Mizutani T, Oda M: Immunoexpression of 14–3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathologica 2003, 106: 66–70.PubMedGoogle Scholar
- van Heusden GP: 14–3-3 proteins: regulators of numerous eukaryotic proteins. IUBMB Life 2005, 57: 623–629.View ArticlePubMedGoogle Scholar
- Acevedo SF, Tsigkari KK, Grammenoudi S, Skoulakis EM: In vivo functional specificity and homeostasis of Drosophila 14–3-3 proteins. Genetics 2007, 177: 239–253. 10.1534/genetics.107.072280View ArticlePubMed CentralPubMedGoogle Scholar
- Lottersberger F, Panza A, Lucchini G, Longhese MP: Functional and physical interactions between yeast 14–3-3 proteins, acetyltransferases, and deacetylases in response to DNA replication perturbations. Molecular and Cellular Biology 2007, 27: 3266–3281. 10.1128/MCB.01767-06View ArticlePubMed CentralPubMedGoogle Scholar
- Chaudhri M, Scarabel M, Aitken A: Mammalian and yeast 14–3-3 isoforms form distinct patterns of dimers in vivo. Biochemical and Biophysical Research Communications 2003, 300: 679–685. 10.1016/S0006-291X(02)02902-9View ArticlePubMedGoogle Scholar
- Aitken A: 14–3-3 proteins: a historic overview. Seminars in Cancer Biology 2006, 16: 162–172. 10.1016/j.semcancer.2006.03.005View ArticlePubMedGoogle Scholar
- Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B: Cooperative effects of genes controlling the G2/M checkpoint. Genes & Development 2000, 14: 1584–1588.Google Scholar
- Nguyen A, Rothman DM, Stehn J, Imperiali B, Yaffe MB: Caged phosphopeptides reveal a temporal role for 14–3-3 in G1 arrest and S-phase checkpoint function. Nature Biotechnology 2004, 22: 993–1000. 10.1038/nbt997View ArticlePubMedGoogle Scholar
- She Q-B, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N: The BAD protein integrates survival signaling by EGFR/MAPK and PI3 K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell 2005, 8: 287–297. 10.1016/j.ccr.2005.09.006View ArticlePubMed CentralPubMedGoogle Scholar
- Porter GW, Khuri FR, Fu H: Dynamic 14–3-3/client protein interactions integrate survival and apoptotic pathways. Seminars in Cancer Biology 2006, 16: 193–202. 10.1016/j.semcancer.2006.03.003View ArticlePubMedGoogle Scholar
- Milton AH, Khaire N, Ingram L, O'Donnell AJ, La Thangue NB: 14–3-3 proteins integrate E2F activity with the DNA damage response. EMBO Journal 2006, 25: 1046–1057. 10.1038/sj.emboj.7600999View ArticlePubMed CentralPubMedGoogle Scholar
- Chong ZZ, Maiese K: Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14–3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. British Journal of Pharmacology 2007, 150: 839–850. 10.1038/sj.bjp.0707161View ArticlePubMed CentralPubMedGoogle Scholar
- Rushworth LK, Hindley AD, O'Neill E, Kolch W: Regulation and role of Raf-1/B-Raf heterodimerization. Molecular & Cellular Biology 2006, 26: 2262–2272. 10.1128/MCB.26.6.2262-2272.2006View ArticleGoogle Scholar
- Gardino AK, Smerdon SJ, Yaffe MB: Structural determinants of 14–3-3 binding specificities and regulation of subcellular localization of 14–3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14–3-3 isoforms. Seminars in Cancer Biology 2006, 16: 173–182. 10.1016/j.semcancer.2006.03.007View ArticlePubMedGoogle Scholar
- Hermeking H, Benzinger A: 14–3-3 proteins in cell cycle regulation. Seminars in Cancer Biology 2006, 16: 183–192. 10.1016/j.semcancer.2006.03.002View ArticlePubMedGoogle Scholar
- Zeng Y, Piwnica-Worms H: DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14–3-3 binding. Molecular & Cellular Biology 1999, 19: 7410–7419.View ArticleGoogle Scholar
- Dalal SN, Yaffe MB, DeCaprio JA: 14–3-3 family members act coordinately to regulate mitotic progression. Cell Cycle 2004, 3: 672–677.View ArticlePubMedGoogle Scholar
- Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang H, Shen J, Zhao RY, Caraway NP, Katz RL, et al.: Up-regulation of 14–3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Research 2007, 67: 7901–7906. 10.1158/0008-5472.CAN-07-0090View ArticlePubMedGoogle Scholar
- Takihara Y, Matsuda Y, Hara J: Role of the beta isoform of 14–3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 2000, 21: 2073–2077. 10.1093/carcin/21.11.2073View ArticlePubMedGoogle Scholar
- Martin D, Brown-Luedi M, Chiquet-Ehrismann R: Tenascin-C signaling through induction of 14–3-3 tau. The Journal of Cell Biology 2003, 160: 171–175. 10.1083/jcb.200206109View ArticlePubMed CentralPubMedGoogle Scholar
- Qi W, Martinez JD: Reduction of 14–3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation. Radiation Research 2003, 160: 217–223. 10.1667/RR3038View ArticlePubMedGoogle Scholar
- Qi W LX, Chen W, Li Q, Martinez JD: Overexpression of 14–3-3gamma causes polyploidization in H322 lung cancer cells. Molecular Carcinogenesis 2007, 46: 847–856. 10.1002/mc.20314View ArticlePubMedGoogle Scholar
- Li W, Skoulakis EM, Davis RL, Perrimon N: The Drosophila 14–3-3 protein Leonardo enhances Torso signaling through D-Raf in a Ras 1-dependent manner. Development 1997, 124: 4163–4171.PubMedGoogle Scholar
- Chang HC, Rubin GM: 14–3-3 epsilon positively regulates Ras-mediated signaling in Drosophila. Genes & Development 1997, 11: 1132–1139. 10.1101/gad.11.9.1132View ArticleGoogle Scholar
- Kockel L, Vorbruggen G, Jackle H, Mlodzik M, Bohmann D: Requirement for Drosophila 14–3-3 zeta in Raf-dependent photoreceptor development. Genes & Development 1997, 11: 1140–1147. 10.1101/gad.11.9.1140View ArticleGoogle Scholar
- Su TT, Parry DH, Donahoe B, Chien CT, O'Farrell PH, Purdy A: Cell cycle roles for two 14–3-3 proteins during Drosophila development. Journal of Cell Science 2001, 114: 3445–3454.PubMed CentralPubMedGoogle Scholar
- Edgar BA, O'Farrell PH: The three postblastoderm cell cycles of Drosophila embryogenesis are regulated in G2 by string. Cell 1990, 62: 469–480. 10.1016/0092-8674(90)90012-4View ArticlePubMed CentralPubMedGoogle Scholar
- Yan N, Huh JR, Schirf V, Demeler B, Hay BA, Shi Y: Structure and activation mechanism of the Drosophila initiator caspase Dronc. Journal of Biological Chemistry 2006, 281: 8667–8674. 10.1074/jbc.M513232200View ArticlePubMedGoogle Scholar
- Bulavin DV, Higashimoto Y, Demidenko ZN, Meek S, Graves P, Phillips C, Zhao H, Moody SA, Appella E, Piwnica-Worms H, Fornace AJ Jr: Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nature Cell Biology 2003, 5: 545–551. 10.1038/ncb994View ArticlePubMedGoogle Scholar
- Hartenstein V, Posakony JW: Sensillum development in the absence of cell division: the sensillum phenotype of the Drosophila mutant string. Developmental Biology 1990, 138: 147–158. 10.1016/0012-1606(90)90184-KView ArticlePubMedGoogle Scholar
- Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B: 14–3-3 sigma is a p53-regulated inhibitor of G2/M progression. Molecular Cell 1997, 1: 3–11. 10.1016/S1097-2765(00)80002-7View ArticlePubMedGoogle Scholar
- Phelps CB, Brand AH: Ectopic gene expression in Drosophila using GAL4 system. Methods (Duluth) 1998, 14: 367–379.View ArticleGoogle Scholar
- Thummel CS, Boulet AM, Lipshitz HD: Vectors for Drosophila P-element-mediated transformation and tissue culture transfection. Gene 1988, 74: 445–456. 10.1016/0378-1119(88)90177-1View ArticlePubMedGoogle Scholar
- Poirie M, Frey F, Hita M, Huguet E, Lemeunier F, Periquet G, Carton Y: Drosophila resistance genes to parasitoids: chromosomal location and linkage analysis. Proceedings Biological Sciences/The Royal Society 2000, 267: 1417–1421. 10.1098/rspb.2000.1158View ArticlePubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.